BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36945646)

  • 1. Mono-ADP-ribosyltransferase 1 (
    Ishiwata-Endo H; Kato J; Oda H; Sun J; Yu ZX; Liu C; Springer DA; Dagur P; Lizak MJ; Murphy E; Moss J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36945646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARH Family of ADP-Ribose-Acceptor Hydrolases.
    Ishiwata-Endo H; Kato J; Yamashita S; Chea C; Koike K; Lee DY; Moss J
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice.
    Watanabe K; Kato J; Zhu J; Oda H; Ishiwata-Endo H; Moss J
    PLoS One; 2018; 13(11):e0207693. PubMed ID: 30500844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARH1 in Health and Disease.
    Ishiwata-Endo H; Kato J; Stevens LA; Moss J
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32092898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the functional ARH1 allele in tumors from ARH1 heterozygous mice and cells affect ARH1 catalytic activity, cell proliferation and tumorigenesis.
    Kato J; Vekhter D; Heath J; Zhu J; Barbieri JT; Moss J
    Oncogenesis; 2015 Jun; 4(6):e151. PubMed ID: 26029825
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kato J; Yamashita S; Ishiwata-Endo H; Oka S; Yu ZX; Liu C; Springer DA; Noguchi A; Peiravi M; Hoffmann V; Lizak MJ; Medearis M; Kim IK; Moss J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair.
    Ishiwata-Endo H; Kato J; Tonouchi A; Chung YW; Sun J; Stevens LA; Zhu J; Aponte AM; Springer DA; San H; Takeda K; Yu ZX; Hoffmann V; Murphy E; Moss J
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Characterization of the Heart and Skeletal Muscle Reveals Widespread Arginine ADP-Ribosylation by the ARTC1 Ectoenzyme.
    Leutert M; Menzel S; Braren R; Rissiek B; Hopp AK; Nowak K; Bisceglie L; Gehrig P; Li H; Zolkiewska A; Koch-Nolte F; Hottiger MO
    Cell Rep; 2018 Aug; 24(7):1916-1929.e5. PubMed ID: 30110646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity.
    Hesse J; Rosse MK; Steckel B; Blank-Landeshammer B; Idel S; Reinders Y; Sickmann A; Sträter N; Schrader J
    Purinergic Signal; 2022 Mar; 18(1):115-121. PubMed ID: 34961895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARTC1-mediated ADP-ribosylation of GRP78/BiP: a new player in endoplasmic-reticulum stress responses.
    Fabrizio G; Di Paola S; Stilla A; Giannotta M; Ruggiero C; Menzel S; Koch-Nolte F; Sallese M; Di Girolamo M
    Cell Mol Life Sci; 2015 Mar; 72(6):1209-25. PubMed ID: 25292337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases.
    Mashimo M; Kato J; Moss J
    DNA Repair (Amst); 2014 Nov; 23():88-94. PubMed ID: 24746921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis.
    Kato J; Zhu J; Liu C; Stylianou M; Hoffmann V; Lizak MJ; Glasgow CG; Moss J
    Cancer Res; 2011 Aug; 71(15):5327-35. PubMed ID: 21697277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways.
    Bu X; Kato J; Moss J
    Biochem Pharmacol; 2019 Sep; 167():44-49. PubMed ID: 30267646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase.
    Oka S; Kato J; Moss J
    J Biol Chem; 2006 Jan; 281(2):705-13. PubMed ID: 16278211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARTC1-mediated VAPB ADP-ribosylation regulates calcium homeostasis.
    Ma X; Li M; Liu Y; Zhang X; Yang X; Wang Y; Li Y; Wang J; Liu X; Yan Z; Yu X; Wu C
    J Mol Cell Biol; 2024 Jan; 15(7):. PubMed ID: 37381178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PARP inhibitor, rucaparib, improves cardiac dysfunction in
    Yamashita S; Bu X; Ishiwata-Endo H; Kato J; Springer D; Noguchi A; Peiravi M; Liu C; Zhang F; Yu ZX; Clevenger R; Keeran K; San H; Lizak MJ; Moss J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36945462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of arginine-ADP-ribosylated protein using recombinant ADP-ribosylarginine hydrolase.
    Ohno T; Tsuchiya M; Osago H; Hara N; Jidoi J; Shimoyama M
    Anal Biochem; 1995 Oct; 231(1):115-22. PubMed ID: 8678289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-ribosylarginine hydrolases and ADP-ribosyltransferases. Partners in ADP-ribosylation cycles.
    Moss J; Zolkiewska A; Okazaki I
    Adv Exp Med Biol; 1997; 419():25-33. PubMed ID: 9193633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role of intracellular mono-ADP-ribosylation in cancer biology.
    Scarpa ES; Fabrizio G; Di Girolamo M
    FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono-ADP-Ribosylation Catalyzed by Arginine-Specific ADP-Ribosyltransferases.
    Stevens LA; Moss J
    Methods Mol Biol; 2018; 1813():149-165. PubMed ID: 30097866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.